Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

Lancet

Volumn 358, Issue 9287, 2001, Pages 1033-1041

  MacMahon, S ^a,b   Neal, B ^a,b   Tzourio, C ^a   Rodgers, A ^a,b   Woodward, M ^a,b   Cutler, J ^a,b   Anderson, C ^a,b   Chalmers, J ^a,b   Ohkubo, T ^a,b   Bouser, M G ^a   Davis, S ^a   Donnan, G ^a   Hansson, L ^a   Harrap, S ^a   Lees, K R ^a   Liu, L ^a   Mancia, G ^a   Omae, T ^a   Reid, J ^a   Sega, R ^a   Terent, A ^a   Warlow, C ^a   Anderson, N ^a   Bladin, C ^a   Chambers, B ^a   Gordon, G ^a   Sharpe, N ^a   Collins, R ^a   Sandercock, P ^a   Simes, J ^a   Sleight, P ^a   Brnabic, A ^a   Colman, S ^a   Francis, L ^a   Lee, A ^a   Gong, L ^a   Bousser, M G ^a   Yamaguchi, T ^a   William, F ^a   Deng, Q ^a   Hu, D X ^a   Wang, W ^a   Wu, A L ^a   Ma, L Y ^a   Tao, Z Y ^a   Biousse, V ^a   Berthet, K ^a   Ben Slamia, L ^a   Le Denmat, C ^a   Crespi, S ^a   Foglia, G ^a   Fujimoto, C ^a   Matsumura, S ^a   Marttala, K ^a   Pettersson, M ^a   Safwenberg, M ^a   Fenton, J ^a   McIlvenna, Y ^a   Currie, R ^a   Bartram, H ^a   Briad, J ^a   Clague, A ^a   Cleverly, Y ^a   Cosson, M ^a   Culpan, A ^a   Douglas, D ^a   Flett, S ^a   Gray, B ^a   Holloway, T ^a   Milne, A ^a   Prasad, R ^a   Ratnasabapathy, Y ^a   Santos, A ^a   Wills, M ^a   Agnew, T ^a   Chapman, N ^a   Lewis, N ^a   Mullane, B ^a   more..

^a UNIVERSITY OF SYDNEY   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDAPAMIDE; PERINDOPRIL; PLACEBO;

ANAMNESIS; ARTICLE; ASIA; AUSTRALIA; BLOOD PRESSURE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EUROPE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHYSICIAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REDUCTION; RISK; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

EID: 0035968623     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)06178-5     Document Type: Article

References (34)

1. Epidemiology of stroke
2. Treatment and secondary prevention of stroke: Evidence, costs, and effects on individuals and populations
3. Collaborative overview of randomised trials of antiplatelet therapy, I: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients
4. Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin
5. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis
6. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST)
7. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis
8. Blood pressure, cholesterol and stroke in eastern Asia
9. Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts
10. Stroke in the Lehigh Valley: Risk factors for recurrent stroke
11. Hypertension and risk of stroke recurrence
12. Long-term risk of recurrent stroke after a first-ever stroke: The Oxfordshire Community Stroke Project
13. The J-curve phenomenon in stroke recurrence
14. Blood pressure control and recurrence of hypertensive brain hemorrhage
15. Blood pressure lowering for the secondary prevention of myocardial infarction and stroke
16. Blood pressure and risk of stroke in patients with cerebrovascular disease
17. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease
18. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials
19. The effects of blood pressure lowering in cerebrovascular disease
20. Effect of antihypertensive treatment in patients having already suffered from stroke: Gathering the evidence
21. Impact of ramipril and vitamin E on cerebrovascular events in the HOPE (Heart Outcomes Prevention Evaluation) trial
22. Post-stroke antihypertensive treatment study: A preliminary result
23. Blood pressure lowering for the secondary prevention of stroke: Rationale and design for PROGRESS
24. Can simple questions assess outcome after stroke?
25. PROGRESS (Perindopril Protection Against Recurrent Stroke Study): Characteristics of the study population at baseline
26. Reliable assessment of the effects of treatment on mortality and major morbidity, I: Clinical trials
27. Reliable assessment of the effects of treatment on mortality and major morbidity, II: Observational studies
28. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
29. Long-term ACE inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients
30. World Health Organization-International Society of Hypertension guidelines for the management of hypertension
31. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastin Survival Study (4S)
32. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
33. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels